SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Novartis AG – NVS

BALA CYNWYD, PA / ACCESSWIRE / May 9, 2018 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Novartis AG (“Novartis” or “the Company”) (NYSE: NVS News) for possible breaches of fiduciary duty and other violations of federal and state law. The investigation concerns whether the Board of Novartis breached their fiduciary duties to shareholders.

Click here to learn more http://www.brodskysmith.com/cases/novartis-ag-nyse-nvs/, or call:877-534-2590. There is no cost or obligation to you.

If you currently own shares of Novartis stock purchased between February 1, 2017 and May 8, 2018 and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, by visiting http://www.brodskysmith.com/cases/novartis-ag-nyse-nvs/, or calling toll free 877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

SOURCE: Brodsky & Smith, LLC

ReleaseID: 499157